基本信息
产品编号: |
C10088 |
||||
产品名称: |
β-Caryophyllene |
||||
CAS: |
87-44-5 |
储存条件 |
粉末 |
室温 |
四年 |
|
|
||||
分子式: |
溶于液体 |
-20℃ |
两年 |
||
分子量 |
204.35 |
|
|
||
化学名: |
(1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
100mg/mL (489.36mM; Need ultrasonic) |
|||
Ethanol |
≥ 176.67mg/mL (864.55mM) |
||||
Water |
< 0.1mg/mL (insoluble) |
||||
体内(现配现用): |
1.请依序添加每种溶剂:10% EtOH→40% PEG300→5% Tween-80→45% saline Solubility: ≥ 13.25mg/mL (64.84mM); Clear solution |
||||
此⽅案可获得 ≥ 13.25mg/mL (64.84mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 132.5mg/mL 的澄清 EtOH 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50μL Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 |
|||||
2.请依序添加每种溶剂:10% EtOH→90% (20% SBE-β-CD in saline) Solubility: 13.25mg/mL (64.84mM); Suspended solution; Need ultrasonic |
|||||
此⽅案可获得 13.25mg/mL (64.84mM) 的均匀悬浊液,悬浊液可⽤于⼝服和腹腔注射。 以 1mL ⼯作液为例,取 100μL 132.5mg/mL 的澄清 EtOH 储备液加到 900μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中,混合均 匀。 |
|||||
3.请依序添加每种溶剂:10% EtOH→90% corn oil Solubility: ≥ 13.25mg/mL (64.84mM); Clear solution |
|||||
此⽅案可获得 ≥ 13.25mg/mL (64.84mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 132.5mg/mL 的澄清 EtOH 储备液加到 900μL ⽟⽶油中,混合均匀。 |
|||||
4.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility: ≥ 2.5mg/mL (12.23mM); Clear solution |
|||||
此⽅案可获得 ≥ 2.5mg/mL (12.23mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50 μ L Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 |
|||||
5.请依序添加每种溶剂:10% DMSO→90% (20% SBE-β-CD in saline) Solubility: 2.5mg/mL (12.23mM); Suspended solution; Need ultrasonic |
|||||
此⽅案可获得 2.5mg/mL (12.23mM) 的均匀悬浊液,悬浊液可⽤于⼝服和腹腔注射。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 900μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中,混合均 匀。 |
|||||
6.请依序添加每种溶剂:10% DMSO→90% corn oil Solubility: ≥ 2.5mg/mL (12.23mM); Clear solution |
|||||
此⽅案可获得 ≥ 2.5mg/mL (12.23mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 900μL ⽟⽶油中,混合均匀。 |
|||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
4.8936mL |
24.4678mL |
48.9356mL |
5mM |
0.9787mL |
4.8936mL |
9.7871mL |
10mM |
0.4894mL |
2.4468mL |
4.8936mL |
生物活性
产品描述 |
一种非变性离子洗涤剂,于提取膜蛋白。 |
靶点 |
Human Endogenous Metabolite |
体外研究 |
Among the tested cancer cells, β-Caryophyllene demonstrates selective anti-proliferative effect against three cancer cell lines, namely HCT 116 (colon cancer, IC50=19μM), PANC-1 (pancreatic cancer, IC50=27μM), and HT29 (colon cancer, IC50=63μM) cells, whereas β-Caryophyllene exhibits either moderate or poor cytotoxic effects against ME-180, PC3, K562 and MCF-7. Results show that β-Caryophyllene possesses higher selectivity towards the colorectal cancer cells (HCT 116), with selectivity index (SI)=27.9, followed by PANC-1 and HT 29 cells with SI=19.6 and 8, respectively. The apoptotic index estimated for β-Caryophyllene treatment on HCT 116 cells after 24 h treatment is 64±0.04. β-Caryophyllene at 10μM concentration, causes significant nuclei condensation after 6 h of treatment. β-caryophyllene exhibits a dose and timedependent inhibitory effect on the motility of HCT 116 cells |
体内研究 |
Treatment with β-Caryophyllene at different doses does not show any effects on swimming speed during the test. Oral treatment with β-Caryophyllene ameliorates the rise in β-amyloid deposition in the transgenic mice in a roughly dosedependent manner, and the two higher doses exhibit almost equal effects in modifying the β-amyloid burden. The number of activated astroglial cells is higher in vehicle-treated mouse brains than in β-Caryophyllene-treated mouse brains with different doses. β-Caryophyllene is effective at reducing the enhancement of the COX-2 protein level found in vehicle-treated APP/PS1 mice[1]. Animals treated with β-Caryophyllene display higher values of object recognition index than their vehicle-treated counterparts [t(14)=4.204, P<0.05]. The total time spent in object exploration during the test trial is not significantly different between β-Caryophyllene-treated and vehicle-treated animals (t(14)=0.5874, P>0.05). Treatment with βCaryophyllene does not significantly alter these seizure-induced neurochemical changes |
推荐实验方法(仅供参考)
Cell Assay |
Panel of human cancer cells such as, pancreatic (PANC-1), colorectal (HCT-116 and HT-29), invasive squamous cell carcinoma (ME-180), leukemia (K562), hormone sensitive and invasive breast cancer cell line (MCF-7), and prostatic (PC3) adenocarcinoma cell lines are used. Cells are incubated in a humidified CO2 incubator at 37°C supplied with 5% CO2. Inhibitory effect of β-Caryophyllene on proliferation of the cell lines is tested using the MTT assay. The selectivity index (SI) for the cytotoxicity of β-Caryophyllene is calculated using the ratio of IC50 of β-Caryophyllene on a normal cell line (NIH-3T3) to the IC50 of β-Caryophyllene on cancer cell lines |
|
|
Animal Administration |
Male double transgenic APP/PS1 mice and wild-type littermates are used. The mice are group housed (3 to 5 animals/cage) with a 12:12-hour light/dark cycle and ad libitum access to food and water. In this experiment, animals are orally treated by gavage with 16, 48, or 144mg/kg of β-Caryophyllene every morning for 10 weeks starting at the age of 7 months. All vehicle solutions are used for the respective control animal treatments and the Morris water maze test is performed |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )